SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Genentech, Inc. (JOBS) Gives Long-Term Forecast to Fend off Roche (JOBS)

March 2, 2009 | 
1 min read
NEW YORK, March 2 (Reuters) - Genentech Inc (DNA.N) provided investors with earnings and revenue growth projections for every year through 2018 as it aimed to demonstrate that the company is worth more than Roche is willing to pay for it.
Mergers & acquisitions
Genentech, Inc. Roche
MORE ON THIS TOPIC
Opportunity of winning. man sees a illuminated trophy door. vector
autoimmune disease
Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren’s study
September 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Microscope icon. Molecule and communication background. Connected lines with dots.
Deals
Novartis bets up to $900M for radioligand therapy from China’s BoomRay
September 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Business handshake trendy halftone art collage banner template. Partnership concept, successful agreement, closing a deal, securing a contract. Modern retro cut out vector illustration
Cancer
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
September 22, 2026
 · 
2 min read
 · 
Tristan Manalac
China flag on bar chart concept with increasing values, economic recovery and business improving after crisis and other catastrophe as economy and businesses reopen again
Manufacturing
Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts
September 21, 2026
 · 
2 min read
 · 
Nick Paul Taylor